The Natural IVF is the type of IVF Cycle that does not include the usage of drugs. It typically follows a natural ovulation cycle. The procedure involves egg collection aligned with the menstrual cycle. It retrieves the egg which is naturally ovulated. Here, your body selects the best egg itself. Mostly, the result of Natural Cycle IVF is retrieving one egg. But in many cases, it may result in zero egg collection.

This method is suitable for women who are still ovulating and want to prevent the usage of stimulation IVF injections or drugs. Also, this is a very sensitive and precise treatment. There are many benefits of Natural IVF playing a vital role. It is suggested to take suggestions and consultancy from the experts. The procedure for egg collection is very quick and just takes around 5 minutes.

In Vitro Fertilization, IVF has many advantages. One of the reasons why most people choose this method is the low cost. The natural cycle IVF cost much less than the conventional IFV method. Also, this procedure does not involve the risk of ovarian hyperstimulation. But, the risk of multiple pregnancies is still there like in conventional IVF.

Below, we have discussed in detail the Natural Cycle IVF procedure along with the advantages and disadvantages. Also, you can get an idea about the Natural Cycle IVF success rates here.

Who Are the Suitable Candidates for Natural IVF?

For being a Natural IVF candidate, you must fulfill the following requirements:

  • You must have regular menstrual cycles
  • Your age must be less than 45 years
  • The uterus must be normal
  • You must not have any medical contraindications
  • No hydrosalpinx

Following are the conditions when Natural Cycle IVF may treat infertility patients:

  • Tubal occlusion
  • In the case of male factor subfertility
  • In case you had any unsuccessful stimulated IVF treatments earlier
  • Endometriosis
  • Pelvic Adhesions
  • If you have low Anti-Mullerian Hormone (AMH) or high Follicle Stimulating Hormone (FSH)
  • If you have any history of hormone-dependent cancer